Evidence map›Paper›PMID 35281051›Full record

ReviewFrontiers in immunology2022

Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection.

Wei Li, Fahim Syed, Richard Yu, Jing Yang, Ying Xia, Ryan F Relich, Patrick M Russell, Shanxiang Zhang, Mandana Khalili, Laurence Huang and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Health influence of SARS-CoV-2 (COVID-19) on cancer: a review.Acta biochimica et biophysica Sinica · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Wei LiDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Fahim SyedDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Richard YuDepartment of Internal Medicine, School of Medicine, University of Nevada, Reno, NV, United States.
Jing YangDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Ying XiaDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Ryan F RelichDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Patrick M RussellDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Shanxiang ZhangDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Mandana KhaliliDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Laurence HuangDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Melissa A KacenaDepartment of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN, United States.
Xiaoqun ZhengSchool of Laboratory Medicine, Wenzhou Medical University, Wenzhou, China.
Qigui YuDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · USUniversity of California, San Francisco · USSecond Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University · CNUniversity of Nevada, Reno · US

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Mentoring Multidisciplinary Patient-Oriented Research in Viral HepatitisK24AA022523 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KHALILI, MANDANA · 2013 to 2023
$1.9M
Alcohol's impact on immunological and virological profiles in HIV patientsUH3AA026218 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI YU, QIGUI A. · 2019 to 2021
$963k
Alcohol's impact on immunological and virological profiles in HIV patientsUH2AA026218 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI YU, QIGUI A. · 2017 to 2018
$318k
NCATS NIH HHS UL1 TR002529NIAAA NIH HHS K24 AA022523NIAAA NIH HHS UH2 AA026218NIAAA NIH HHS UH3 AA026218
6 · The paper itself

Abstract

Immune checkpoints (ICPs) consist of paired receptor-ligand molecules that exert inhibitory or stimulatory effects on immune defense, surveillance, regulation, and self-tolerance. ICPs exist in both membrane and soluble forms

Indexed as

AlcoholismBiomarkersCOVID-19HIV-1HIV InfectionsHumansImmune Checkpoint ProteinsNeoplasmsSARS-CoV-2Severity of Illness IndexBiomarkersImmune Checkpoint Proteinsalcohol-associated liver disease (ALD)COVID-19heavy alcohol userHIVimmune checkpointinflammationsoluble immune checkpoint

Identifiers

PMID35281051
PMCPMC8904355
OpenAlexW4220853854

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.